Abstract:A recombinant Newcastle disease virus (NDV) expressing the green fluorescent protein (GFP) was generated by applying reverse genetics techniques. The GFP open reading frame flanked by NDV transcription start and stop sequences was inserted between the phosphoprotein (P) and matrix protein (M) in a full-length cDNA clone of NDV Lasota vaccine strain. This plasmid transcribing antigenome RNA was cotransfected with helper plasmids expressing viral nucleoprotein, phosphoprotein and large protein into cells stably expressing T7 RNA polymerase. The rescued virus was first propagated in 10-day-old embryonated eggs and the allantoic fluid was used to infect primary chicken embryo fibroblasts (CEF) cells. The appearance of GFP in live infected cells confirmed further the recovery of a recombinant NDV (rNDV-GFP) expressing this reporter gene. Nine successive passages in embryonated chicken eggs were performed. Allantoic fluid samples were then titrated by a microtiter plate HA test. HA positive ailantoic fluid were used for further egg passages. All the allantoic fluid samples were titrated by end point dilutions and infected cells were examined for the presence of GFP expression. To analyze virus growth, 10-day-old embryonated SPF chicken eggs were inoculated with 1 x 10(4) EID50 rNDV or rNDV-GFP. At 24,48,72 and 96 h p.i. the allantoic fluid of inoculated eggs containing live embryos was harvested and clarified by centrifugation. Supernatants were used for titration of EID50 in 10-day-old embryonated SPF chicken eggs. rNDV and rNDV-GFP grew to similar titers (10(9) EID50/mL). In order to test the virulence of rNDV-GFP, infectious allantoic fluid of rNDV-GFP were inoculated into embryonated SPF chicken eggs at 1 x 10(6) EID50. No dead embryonated egg was found within 96 hours. The replication kinetics and pathogenicity in SPF embryonated eggs of rNDV-GFP did not differ significantly from that of the parent virus. LaSota is a widely used NDV live vaccine strain. The reverse genetic system established for this LaSota vaccine strain provided a useful platform for development of novel live viral vector vaccines in future.

Establishment of Reverse Genetics for Genotype VII Newcastle Disease Virus and Altering the Cell Tropism by Inserting TMPRSS2 into the Viral Genome

Development of a Reverse Genetics System Based on RNA Polymerase II for Newcastle Disease Virus Genotype VII

Rescue of an Enterotropic Newcastle Disease Virus Strain ZM10 from Cloned Cdna and Stable Expressing an Inserted Foreign Gene

Evaluation of the Safety and Protection Efficacy of an Attenuated Genotype Vii Newcastle Disease Virus Strain As a Candidate Vaccine.

Genetic characterization and phylogenetic analysis of Newcastle disease virus from China.

An Improved Reverse Genetics System for Newcastle Disease Virus Genotype VII

Generation and evaluation of a vaccine candidate of attenuated and heat-resistant genotype VIII Newcastle disease virus

Rescue of Recombinant Newcastle Disease Virus by Reverse Genetic System

Potential of Genotype VII Newcastle Disease Viruses to Cause Differential Infections in Chickens and Ducks.

Rescue of a recombinant Newcastle disease virus strain R2B expressing green fluorescent protein

Genetic characterization and distribution of the virus in chicken embryo tissues infected with Newcastle disease virus isolated from commercial and native chickens in Indonesia

Attenuation of GPMV NA-1 Strain by Reverse Genetics Technique

Characterization of a Recombinant Listeria Monocytogenes Strain Containing the Fusion Protein Gene of Newcastle Disease Virus

Role of Macrophages in the Pathogenesis of Genotype VII Newcastle Disease Virus in Chickens

Rescue of Duck-Origin Virulent Newcastle Disease Virus from Cloned Cdna and Stable Expression of the Red Fluorescent Protein

Evaluation of Fusion Protein Cleavage Site Sequences of Newcastle Disease Virus in Genotype Matched Vaccines

Development of an improved reverse genetics system for avian metapneumovirus (aMPV): A novel vaccine vector protects against aMPV and infectious bursal disease virus

Screening and Mechanistic Study of Key Sites of the Hemagglutinin-Neuraminidase Protein Related to the Virulence of Newcastle Disease Virus

The Advancement on Recombinant Newcastle Disease Virus As a Vaccine Vector

Establishing Reverse Genetic System of Thermostable Avirulent Newcastle Disease Virus Strain TS09-C

Rescue of a recombinant Newcastle disease virus expressing the green fluorescent protein]